Your browser doesn't support javascript.
loading
Karyotypic and fluorescent in-situ hybridization study of the centromere of chromosome 7 in secondary myeloid neoplasms
Tanizawa, Roberta Sandra da Silva; Kumeda, Cristina Aiko; Azevedo Neto, Raymundo Soares de; Leal, Aline de Medeiros; Ferreira, Patrícia de Barros; Velloso, Elvira Deolinda Rodrigues Pereira.
  • Tanizawa, Roberta Sandra da Silva; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Serviço de Hematologia Cytogenetics Laboratory. São Paulo. BR
  • Kumeda, Cristina Aiko; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Serviço de Hematologia Cytogenetics Laboratory. São Paulo. BR
  • Azevedo Neto, Raymundo Soares de; Universidade de São Paulo. Faculdade de Medicina. Pathology Service. São Paulo. BR
  • Leal, Aline de Medeiros; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Serviço de Hematologia Cytogenetics Laboratory. São Paulo. BR
  • Ferreira, Patrícia de Barros; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Serviço de Hematologia Cytogenetics Laboratory. São Paulo. BR
  • Velloso, Elvira Deolinda Rodrigues Pereira; Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas. Serviço de Hematologia Cytogenetics Laboratory. São Paulo. BR
Rev. bras. hematol. hemoter ; 33(6): 425-431, Dec. 2011. ilus, tab
Article in English | LILACS | ID: lil-611378
ABSTRACT

BACKGROUND:

Secondary myeloid neoplasms comprise a group of secondary diseases following exposure to myelotoxic agents or due to congenital diseases. The improvement of anticancer agents and immunosuppressive drugs seem to be associated with an increased incidence of secondary myeloid neoplasms. Karyotyping of bone marrow is essential for diagnosis and prognosis. Previous use of alkylating agents and radiation are associated with clonal abnormalities such as recurrent unbalanced -5/5q-, -7/7q- and complex karyotypes, whereas topoisomerase-II inhibitors lead to changes such as the balanced 11q23 rearrangement, t(8;21), t(15;17) and inv(16).

OBJECTIVE:

To study the clinical and cytogenetic data of patients with secondary myeloid neoplasms who took antineoplastic and/or immunosuppressive drugs or progressed from aplastic anemia.

METHODS:

The clinical and cytogenetic characteristics of 42 patients diagnosed with secondary myeloid neoplasms in one institution were retrospectively evaluated. Of these, 25, 11 and 6 patients had had oncological diseases, aplastic anemia and other diseases, respectively. Conventional cytogenetic and FISH analyses were performed for monosomy 7.

RESULTS:

The cytogenetic study was conclusive in 32 cases with 84.4 percent of clonal abnormalities. Monosomy 7 and complex karyotypes were present in 44.4 percent and 37 percent, respectively. A high prevalence of unbalanced abnormalities (96.3 percent) was observed. Monosomy 7 was more prevalent in patients with myelodysplastic syndromes/myeloid neoplasms after aplastic anemia (66.6 percent). The median survival after diagnosis of myeloid neoplasms was only 5.7 months. Normal cytogenetics was associated to better survival (p-value = 0.03). There was a slightly worse trend of survival for patients with complex karyotypes (p-value = 0.057). Abnormal karyotype was an independent risk factor for poor survival (p-value = 0.012).

CONCLUSION:

This study enhances the importance ...
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Neoplasms, Second Primary / Karyotyping Type of study: Prognostic study / Risk factors Limits: Humans Language: English Journal: Rev. bras. hematol. hemoter Journal subject: Hematology Year: 2011 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Neoplasms, Second Primary / Karyotyping Type of study: Prognostic study / Risk factors Limits: Humans Language: English Journal: Rev. bras. hematol. hemoter Journal subject: Hematology Year: 2011 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR